New data demonstrate that Lecanemab , an experimental drug, could lessen the advance of preclinical Alzheimer's . This medication works by clearing amyloid plaques from the mind, a crucial https://lancelwzi201711.mpeblog.com/73641582/nadecenemab-a-emerging-novel-dementia-treatment